ESPR compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ESPREsperion Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ESPREsperion Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ESPR

0 of 4at or beyond implied

Reportimpliedrealized× implied

Mar 10 '26±15.3%▼−11.18%×0.73

Jan 12 '26±9.3%▼−8.51%×0.91

Nov 6 '25±21.8%▼−14.97%×0.69

Aug 5 '25±19.8%▲+8.72%×0.44

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 29 '26±5.1%▲+6.63%×1.29

Aug 5 '26±6.2%▲+4.86%×0.79

= impliedESPR realized, solidLLY realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

Apr 30 '26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ESPREsperion Therapeutics, Inc.

3.19▼−0.16%· post 3.20

Mkt cap$818.6MRevenue$80MQ1 FY26Revenue$403MFY25

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

ClosedNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 6 '26

ESPREsperion Therapeutics, Inc.

LLYELI Lilly & Co

3.19▼−0.16%post 3.20

Price

1,360.90▼−0.28%post 1,358.90

$818.6M

Mkt cap

$1.2T

Q1 FY26$80M

Revenue

$24.4BQ3 FY26

FY25$403M

Revenue

$65.2BFY25

ESPR3.19▼−0.16%vsLLY1,360.90▼−0.28%ClosedNov 6 '26